spectrumK gives the starting signal for the fifth round of tenders

16.11.2012 17:28

The healthcare service provider spectrumK has today published a tender for generic medicines in the EU Official Journal under reference number 012/S 219-360770 for the fifth time in a row.

This time, 32 active ingredients are being advertised in the form of 47 lots, labeled according to potency, dosage form and pack size. New are generic active ingredients such as irbesartan for the treatment of hypertension and Heart failure as well as desogestrel/ethinyl estradiol for hormonal Pregnancy prevention. Frequently prescribed non-prescription medicines such as acetylsalicylic acid (to inhibit platelet aggregation), ambroxol (cough reliever) and saline solution are also included in this tranche. “Thanks to our closely scheduled tenders, the health insurance companies always benefit from the most economical offer. In this way, we constantly support the supply of over 8 million insured people with equally high-quality and affordable medications,” says Yves Rawiel, Managing Director of spectrumK GmbH. The new contracts are scheduled to start in April 2013 and supplement the existing contracts.

As a healthcare service provider, spectrumK offers a wide range of products for health insurance companies and their insured persons, primarily in the areas of care, finance and information management. spectrumK GmbH provides its customers with tailored services based on comprehensive industry know-how.